Pressure BioSciences Inc. (OTCQB: PBIO) CEO Richard T. Schumacher earlier this week hosted a webinar update and live Q&A session for prospective investors. During the presentation, Schumacher detailed each of PBIO’s three distinct working groups, including its Research Products and Services division, its Biopharmaceutical Manufacturing division and its third group specializing in the development and implementation of the company’s cutting-edge Ultra Shear Technology (“UST”) platform. “The company’s really split now into three different working groups. We’ve made an acquisition and we’ve gotten a new patent that’s been approved, all in the last several months, and it’s changed the face of the company a great deal… We’re looking forward to a very very interesting year for Pressure Biosciences,” Schumacher stated during the update. Additional topics discussed during the presentation include the company’s newly-expanded salesforce and its December 2017 acquisition of BaroFold Inc.’s asset portfolio, as well as a brief outlook for the 2018 fiscal year.
To view the full webinar, visit http://ibn.fm/QTtja
About Pressure BioSciences Inc.
Pressure BioSciences Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of our patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
